1 / 4Oral Research Compounds
90 Capsules | Finished in the USA
Orforglipron Capsules — 90 count · Default
$132.00$220.00
For Research Use Only. Not for human or veterinary use. Not for use in diagnostic or therapeutic procedures. Not for food, drug, or cosmetic use.
90 Capsules | Finished in the USA
Orforglipron is a small-molecule, non-peptide GLP-1 receptor agonist. It appears in published research examining GLP-1 receptor binding and incretin pathway signaling — notable for achieving receptor engagement without a peptide backbone.
For Research Use Only. Not for human or veterinary use.
Orforglipron is a small-molecule GLP-1 receptor agonist. It is not a peptide — which is precisely what makes it a research subject. Most compounds engaging the GLP-1 receptor are peptide-based, and achieving comparable receptor activity with a small molecule represents a distinct pharmacological approach.
Published research examines Orforglipron in receptor binding assays and in comparative work against peptide-based incretin compounds.
A small-molecule, non-peptide GLP-1 receptor agonist, supplied as a laboratory research compound in 90-count capsule format.
No. It is a small molecule. Engaging the GLP-1 receptor without a peptide structure is its primary research interest.
GLP-1 receptor binding, incretin pathway signaling, and comparative pharmacology against peptide-based receptor agonists.
Orforglipron is a small molecule; semaglutide and tirzepatide are peptides. They engage overlapping receptor targets through different structural approaches.
No. It is an investigational compound, supplied strictly for laboratory research.
Yes, per lot, through Freedom Diagnostics and Kovera. COAs are available at realpeptides.co/coas.
Cool, dry conditions, protected from light. Refer to the lot COA.
No. Real Peptides holds domestic inventory and ships from its own stock.
No. It is supplied strictly as a laboratory research compound — not a drug, food, cosmetic, or medical device, and not for human or veterinary use.
Research library
